GlassScriptPhysician profile
Scott A Mayerberger
NPI 1073614145
$981.43
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $89.88 · 2021: $125 · 2022: $113 · 2023: $54.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $406.08 | 2019-2023 | Zubsolv |
| Daiichi Sankyo INC. | $168.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.75 | 2019-2022 | |
| Nevro Corp. | $67.77 | 2019-2021 | |
| Redhill Biopharma INC. | $49.91 | 2020-2021 | |
| Shionogi INC | $34.54 | 2019 | |
| G Medical Diagnostic Services, INC. | $21.43 | 2021 | |
| Collegium Pharmaceutical, INC. | $20.80 | 2019 | |
| Zyla Life Sciences, INC. | $20.68 | 2019 | |
| Lilly USA, LLC | $17.56 | 2023 | Mounjaro |
| Horizon Therapeutics Plc | $16.35 | 2021 | |
| Biodelivery Sciences International, INC. | $14.87 | 2020 | |
| Kaleo, INC. | $14.47 | 2019 | |
| Titan Pharmaceuticals, INC. | $12.07 | 2019 | |
| Sentynl Therapeutics, INC. | $11.96 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mayerberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.